Anonymous wrote:
To the poster above, how old was your son when you started tx with leucovorin?
I’m the PP. DS was 11. They’ve apparently seen improvement even in 40+ old adults but earlier intervention better.
Anonymous wrote:Anonymous wrote:Anonymous wrote:The AP has a good summary here: https://apnews.com/article/autism-drug-leucovorin-trump-kennedy-d2b36faef3c4fc1f85e9fa9f958ad6c6
20 years ago researchers theorized low levels of folate in the brain caused by antibodies blocking its absorption could be a cause of autism in some people. But then a study showed non-autistic siblings also had the low folate levels so that theory was kind of abandoned.
Then in 2018 Frye published a study of 48 children showing those that took leucovorin did better than those that didn't. Since then he has had trouble getting funding to do more research on this. Outside of the US 4 other small studies with different methodologies have also shown a benefit.
This year Frye approached the Trump administration hoping to test a new proprietary version of the drug. To Frye's surprise the FDA just approved the use of the existing drug for autism.
Seems like this really does need to be studied more. The FDA approval is just a political move to make it seem like they are doing something when it is not actually meaningful.
I’m the PP who said I was going to give it a try. To me, it’s unfortunate that the researcher is pushing for a proprietary version of what is essentially a generic drug—it feels off that he’s trying to monetize something that’s already accessible. No wonder he was surprised by the FDA approval; his approach seems to hinge on having more time to show results with his formula.
That said, I still think the existing RCTs are solid enough to suggest a real benefit, especially given the low risk of adverse effects compared to the potential upside. For that reason, I believe it’s worth trying for my child.
Leucovorin, which is what Dr Frye prescribes, is an existing, long out of patent drug that is dirt cheap. You have your facts confused.
GlaxoSmithKline is repackaging their version of it into wellcovorin. I doubt Dr. Frye owns GlaxoSmithKline.
Anonymous wrote:Anonymous wrote:The AP has a good summary here: https://apnews.com/article/autism-drug-leucovorin-trump-kennedy-d2b36faef3c4fc1f85e9fa9f958ad6c6
20 years ago researchers theorized low levels of folate in the brain caused by antibodies blocking its absorption could be a cause of autism in some people. But then a study showed non-autistic siblings also had the low folate levels so that theory was kind of abandoned.
Then in 2018 Frye published a study of 48 children showing those that took leucovorin did better than those that didn't. Since then he has had trouble getting funding to do more research on this. Outside of the US 4 other small studies with different methodologies have also shown a benefit.
This year Frye approached the Trump administration hoping to test a new proprietary version of the drug. To Frye's surprise the FDA just approved the use of the existing drug for autism.
Seems like this really does need to be studied more. The FDA approval is just a political move to make it seem like they are doing something when it is not actually meaningful.
I’m the PP who said I was going to give it a try. To me, it’s unfortunate that the researcher is pushing for a proprietary version of what is essentially a generic drug—it feels off that he’s trying to monetize something that’s already accessible. No wonder he was surprised by the FDA approval; his approach seems to hinge on having more time to show results with his formula.
That said, I still think the existing RCTs are solid enough to suggest a real benefit, especially given the low risk of adverse effects compared to the potential upside. For that reason, I believe it’s worth trying for my child.
Anonymous wrote:Anonymous wrote:The AP has a good summary here: https://apnews.com/article/autism-drug-leucovorin-trump-kennedy-d2b36faef3c4fc1f85e9fa9f958ad6c6
20 years ago researchers theorized low levels of folate in the brain caused by antibodies blocking its absorption could be a cause of autism in some people. But then a study showed non-autistic siblings also had the low folate levels so that theory was kind of abandoned.
Then in 2018 Frye published a study of 48 children showing those that took leucovorin did better than those that didn't. Since then he has had trouble getting funding to do more research on this. Outside of the US 4 other small studies with different methodologies have also shown a benefit.
This year Frye approached the Trump administration hoping to test a new proprietary version of the drug. To Frye's surprise the FDA just approved the use of the existing drug for autism.
Seems like this really does need to be studied more. The FDA approval is just a political move to make it seem like they are doing something when it is not actually meaningful.
Lord. quacks all the way down.
Anonymous wrote:Anonymous wrote:The AP has a good summary here: https://apnews.com/article/autism-drug-leucovorin-trump-kennedy-d2b36faef3c4fc1f85e9fa9f958ad6c6
20 years ago researchers theorized low levels of folate in the brain caused by antibodies blocking its absorption could be a cause of autism in some people. But then a study showed non-autistic siblings also had the low folate levels so that theory was kind of abandoned.
Then in 2018 Frye published a study of 48 children showing those that took leucovorin did better than those that didn't. Since then he has had trouble getting funding to do more research on this. Outside of the US 4 other small studies with different methodologies have also shown a benefit.
This year Frye approached the Trump administration hoping to test a new proprietary version of the drug. To Frye's surprise the FDA just approved the use of the existing drug for autism.
Seems like this really does need to be studied more. The FDA approval is just a political move to make it seem like they are doing something when it is not actually meaningful.
I’m the PP who said I was going to give it a try. To me, it’s unfortunate that the researcher is pushing for a proprietary version of what is essentially a generic drug—it feels off that he’s trying to monetize something that’s already accessible. No wonder he was surprised by the FDA approval; his approach seems to hinge on having more time to show results with his formula.
That said, I still think the existing RCTs are solid enough to suggest a real benefit, especially given the low risk of adverse effects compared to the potential upside. For that reason, I believe it’s worth trying for my child.
Anonymous wrote:The AP has a good summary here: https://apnews.com/article/autism-drug-leucovorin-trump-kennedy-d2b36faef3c4fc1f85e9fa9f958ad6c6
20 years ago researchers theorized low levels of folate in the brain caused by antibodies blocking its absorption could be a cause of autism in some people. But then a study showed non-autistic siblings also had the low folate levels so that theory was kind of abandoned.
Then in 2018 Frye published a study of 48 children showing those that took leucovorin did better than those that didn't. Since then he has had trouble getting funding to do more research on this. Outside of the US 4 other small studies with different methodologies have also shown a benefit.
This year Frye approached the Trump administration hoping to test a new proprietary version of the drug. To Frye's surprise the FDA just approved the use of the existing drug for autism.
Seems like this really does need to be studied more. The FDA approval is just a political move to make it seem like they are doing something when it is not actually meaningful.
Anonymous wrote:The AP has a good summary here: https://apnews.com/article/autism-drug-leucovorin-trump-kennedy-d2b36faef3c4fc1f85e9fa9f958ad6c6
20 years ago researchers theorized low levels of folate in the brain caused by antibodies blocking its absorption could be a cause of autism in some people. But then a study showed non-autistic siblings also had the low folate levels so that theory was kind of abandoned.
Then in 2018 Frye published a study of 48 children showing those that took leucovorin did better than those that didn't. Since then he has had trouble getting funding to do more research on this. Outside of the US 4 other small studies with different methodologies have also shown a benefit.
This year Frye approached the Trump administration hoping to test a new proprietary version of the drug. To Frye's surprise the FDA just approved the use of the existing drug for autism.
Seems like this really does need to be studied more. The FDA approval is just a political move to make it seem like they are doing something when it is not actually meaningful.
Anonymous wrote:Anonymous wrote:Anonymous wrote:A good summary of the research: https://www.youtube.com/watch?v=RpV23RJzqnU
No, that is a YouTube video by a non-MD who calls herself a “Dr.” Exactly the wrong place to look.
She is a chemist PhD, also a Doctor.
Anonymous wrote:Anonymous wrote:A good summary of the research: https://www.youtube.com/watch?v=RpV23RJzqnU
No, that is a YouTube video by a non-MD who calls herself a “Dr.” Exactly the wrong place to look.
Anonymous wrote:A good summary of the research: https://www.youtube.com/watch?v=RpV23RJzqnU